Prevalence of dyslipidemia in newly diagnosed patients of type-2 diabetes mellitus at tertiary care centre of West Uttar Pradesh: A single centre study

Yogita Singh, Devinder Kumar Vohra, Mohd. Misbahuzzama Khan, Ganesh Singh


Literature from Indian studies showed a threefold rise in the prevalence of diabetes in rural as well as urban areas and India may become the diabetic capital of the world in near future. Patients suffering from type 2 DM have more risk of developing vascular diseases because of changes in lipid profile. Diabetic dyslipidemia is more atherogenic and is characterised by increase in serum levels of total cholesterol (TC), triglycerides (TGs), or both, or decrease in serum levels of high-density lipoprotein cholesterol (HDL-C). Dyslipidemia is a risk factor for cardiovascular diseases and is modifiable. The present study was conducted to determine the prevalence of dyslipidemia in newly-diagnosed patients of type-2 diabetes mellitus. In the study, 100 newly diagnosed type 2 diabetes patients were included as cases and 100 non-diabetic subjects were included as controls. Blood samples were collected from the subjects of both the study and control groups and were analyzed for fasting and post-prandial plasma glucose, HbA1c, TC, TG, LDL-C, and HDL-C. 84% of cases had dyslipidemia whereas only 52% of controls were found to have dyslipidemia and the difference between the two groups was statistically significant (p<0.05). The mean values of fasting and post-prandial plasma glucose, HbA1c, TC, TG and LDL-C were found to be higher in the cases as compared to the controls (p<0.05). Positive correlation was found between glycemic parameters and Serum – total cholesterol, triglycerides and LDL cholesterol (p<0.05). This study demonstrated that the dyslipidemia is prevalent in newly diagnosed T2DM patients. Hence this study stresses the need and importance of implementation of measures to control dyslipidemia in diabetic patients as dyslipidemia is a known risk factor for cardiovascular diseases.

Keywords: Type 2 diabetes mellitus, HbA1c (Glycosylated haemoglobin), Fasting blood glucose, Dyslipidemia, Triglycerides, High density lipoprotein-cholesterol.

Full Text:



American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2009;32(S1):S62-S7.

Guyton AC, Hall JE. In: Insulin glucagon and diabetes mellitus Textbook of Medical Physiology. Saunder’s Philadelphia, 12th edition; 2013, p. 618-22.

Tripathi BK, Srivastava AK. Diabetes mellitus: complications and therapeutics. Med Sci Monit 2006;12:RA130-47.

Maruthur NM. The growing prevalence of type 2 diabetes: increased incidence or improved survival? Curr Diab Rep 2013;13:786-94.

International Diabetes Federation Diabetes Atlas, Eighth Edition, 2017. Available at:

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J 2014;7(1):45-8.

DeFronzo RA, Ferrannini E, Zimmet P. International Textbook of Diabetes Mellitus, 2 Volume Set, 4th Edition. Wiley-Blackwell, 2015.

Fendler W, Borowiec M, Baranowska-Jazwiecka A. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia 2012;55:2631–5.

Ambrish Mithal, Debashish Majhi, M. Shunmugavelu, Pradeep G. Talwarkar, Hardik Vasnawala, Ammar S. Raza. Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID). Indian J Endocrinol Metab 2014;18(5):642–7.

Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009;5:150-9.

Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:1225-36.

Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis 2014;13:183.

Bardini G, Rotella CM, Giannini S. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud 2012;9:82-93.

Gupta R, Rao RS, Misra A, Sharma SK. Recent trends in epidemiology of dyslipidemias in India. Indian Heart J 2017;69(3):382-92.

American Diabetes Association-Classification and Diagnosis of Diabetes: Diabetes Care 2017;40(S1):S11-S24.

Executive summary of the Third Report of the National Cholesterol Education Programme (NCEP)(2001) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-97.

Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nat 2001;414(6865):813-20.

Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003;46(6):733-49.

Lorber D. Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 2014;7:169-83.

Krauss RM, Siri PW. Dyslipidemia in type 2 diabetes. Med Clin N Am 2004;88(4):897-909.

Venkatesh SK, Sudheer K. M. V., Mohana Krishna T. Lipid profile analysis of type 2 diabetic patients in Bengaluru population, India. Int J Res Med Sci 2018;6(6):2049-53.

Agrawal Yuthika, Goyal Vipin, Chugh Kiran, Shanker Vijay, Singh Anurag Ambroz. Types of dyslipidemia in Type 2 diabetic patients of Haryana region. Sch J App Med Sci 2014;2(4D):1385-92.

Gamit DN, Mishra A. A lipid profile study amongst the patients of type 2 diabetes mellitus - A cross sectional study. IAIM 2018;5(2):1-5.

Bali K. Pattern of dyslipidemia in Type 2 Diabetes Mellitus in Punjab. Int J Res Med Sci 2016;4(3):809-12.